Access cutting-edge end-stage kidney disease treatment through this clinical trial at a research site in Jackson. Study-provided care at no cost to qualified participants.
Access end-stage kidney disease specialists in Jackson at no cost
This study follows strict safety protocols and ethical guidelines
All study-related end-stage kidney disease treatment provided free
The aim of this study is to learn about the safety of empagliflozin in dialysis patients as a preparation for a future large clinical trial. Empagliflozin has been approved by the Food and Drug Administration for the treatment of either type 2 diabetes, heart failure, or chronic kidney disease among patients not on dialysis. The use of empagliflozin has not been studied or approved among patients on dialysis for kidney failure because empagliflozin acts on the kidneys. However, recent experiment
Sponsor: University of Mississippi Medical Center
Check if you qualify for this end-stage kidney disease clinical trial in Jackson, MS
If you're searching for end-stage kidney disease treatment options in Jackson, MS, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Jackson research site is actively enrolling participants for this clinical trial. You'll receive care from experienced end-stage kidney disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.